pravastatin has been researched along with Airflow Obstruction, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, NC; Chen, CC; Lee, TM; Shen, HN | 1 |
| Corte, TJ; Wort, SJ | 1 |
| Chang, NC; Lee, TM; Lin, MS | 1 |
2 trial(s) available for pravastatin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Topics: Adult; Aged; Aged, 80 and over; Endothelin-1; Exercise Tolerance; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Lipids; Male; Middle Aged; Pravastatin; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2009 |
Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
Topics: Aged; Biomarkers; C-Reactive Protein; Cholesterol; Double-Blind Method; Dyspnea; Exercise Test; Exercise Tolerance; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Pravastatin; Pulmonary Disease, Chronic Obstructive | 2008 |
1 other study(ies) available for pravastatin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
Topics: Exercise Tolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Pravastatin; Pulmonary Disease, Chronic Obstructive | 2009 |